T. Purdon

Neurotoxicity Associated with CD19-specific Chimeric Antigen Receptor T cell Therapy for Adult Acute Lymphoblastic Leukemia (B-ALL) (S23.008)

M. Sadelain, B. Sénéchal, B. Santomasso, 2018, Neurology.

CD19-Targeted 19-28z CAR Modified Autologous T Cells Induce High Rates of Complete Remission and Durable Responses in Adult Patients with Relapsed, Refractory B-Cell ALL

M. Sadelain, K. Curran, R. Brentjens, 2014 .